Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth#United_States#Cranford#Citius_Pharmaceuticals#LYMPHIR#Nasdaq_CTXR
Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth
Citius Pharmaceuticals has successfully finalized a direct offering worth $6 million. The proceeds will propel the launch of its innovative product, LYMPHIR, and further its development initiatives.
third-news.com
October 21, 2025 at 8:31 PM
Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth#United_States#Cranford#Citius_Pharmaceuticals#LYMPHIR#Nasdaq_CTXR